Roberto Latini Got His Medical Doctor Degree in 1978 at the University of Milan

CURRICULUM VITAE

Roberto Latini got his Medical Doctor degree in 1978 at the University of Milan.

Education

1970-1978University of Milan School of Medicine, degree in Medicine

1981-1983Merck Sharp & Dohme International Fellow in Clinical Pharmacology. Cardiology Fellow, Stanford University Medical Center, California, USA

Main fields of activity

Mechanisms of cardiac damage following ischemia, with focus on neurohumoral activation. Use of stem cells for cardiac repair. Biohumoral investigations within large scale clinical trials in heart failure and atrial fibrillation.

Positions

from Mar 2013Director of the Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy

from 1991Member of the Steering Committees of the randomized clinical trial: ALOFT, ValHeFT, GISSI-HF, GISSI-AF, CandHeart, CYCLE, ICOS-ONE.

from 1990Head of the Cardiovascular Clinical Pharmacology Laboratory (Department of Cardiovascular Research) Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy

1999-2009Visiting Professor Dept of Medicine, New York Medical College, Valhalla, NY, USA

1981-1983Cardiology Fellow (Dr. R. E. Kates, Laboratory) Stanford University Medical Center, CA, USA

1976-1981Member of the Sub-Group RMs for Drugs (Community Bureau of Reference, Commission of the European Communities)

1973-1990Fellow at the Laboratory of Clinical Pharmacology of the Istituto di Ricerche Farmacologiche "Mario Negri", Milano, Italy

PUBLICATIONS

Askevold ET, Aukrust P, Nymo SH , Lunde IG, Kaasbøll OJ, Aakhus S, Florholmen G, Ohm IK, Strand ME, Attramadal H, Fiane A, Dahl CP, Finsen AV, Vinge LE, Christensen G, Yndestad A, Gullestad L, Latini R, Masson S, Tavazzi L, GISSI-HF Investigators, Ueland T

The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure

J Intern Med 2014; 275: 621-630

Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, Fanizza C, Caspani L, Faenza S, Grasselli G, Iapichino G, Antonelli M, Parrini V, Fiore G, Latini R, Gattinoni L, for the ALBIOS Study Investigators

Albumin replacement in patients with severe sepsis or septic shock

New Engl J Med 2014; 370: 1412-1421

Cannone V, Barlera S, Pileggi S, Masson S, Franzosi MG, Latini R, Scardulla C, Clemenza F, Maggioni AP, Nicolosi GL, Tavazzi L, Burnett JC Jr, GISSI-HF Investigators

The Anp genetic variant Rs5068 and circulating levels of natriuretic peptides in patients with chronic heart failure

Int J Cardiol 2014; Epub

Fumagalli F, Russo I, Staszewsky L, Li Y, Letizia T, Masson S, Novelli D, Rocchetti M, Canovi M, Veglianese P, Gobbi M, Latini R, Zaza A, Ristagno G

Ranolazine ameliorates post-resuscitation electrical instability and myocardial dysfunction and improves survival with good neurological recovery in a rat model of cardiac arrest

Heart Rhythm 2014; 11: 1641-1647

Guzzetti S, Bassani T, Latini R, Masson S, Barlera S, Citerio G, Porta A

Autonomic cardiovascular modulation with three different anesthetic strategies during neurosurgical procedures

Minerva Anestesiol 2014, Epub

Latini R, Masson S

Circulating cardiac biomarkers and outcome. Chapter 20

In: Gullo A, Ristagno G (eds) Resuscitation. Springer-Verlag Italia Milano, 2014; 211-217

Masson S, Agabiti N, Vago T, Miceli M, Mayer F, Letizia T, Wienhues-Thelen U, Mureddu GF, Davoli M, Boccanelli A, Latini R, on behalf of the Investigators of the PREDICTOR Study

The fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk

J Intern Med 2014; Epub

Masson S, Caironi P, Spanuth E, Thomae R, Panigada M, Sangiorgi G, Fumagalli R, Mauri T, Isgrò S, Fanizza C, Romero M, Tognoni G, Latini R, Gattinoni L

Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial

Crit Care 2014; 18: R6

Nobili A, Pasina L. Latini R

Beta-adrenoceptor antagonists and antianginal drugs. Chapter 18

In: Aronson JK, Side Effects of Drugs. Annual 35

Elsevier, Amsterdam 2014; 351-357

Palazzuoli A, Masson S, Ronco C, Maisel M

Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin

Heart Fail Rev 2014; 19: 267-284

Ristagno G, Fumagalli F, Russo I, Tantillo S, Zani D D, Locatelli V, De Maglie M, Novelli D, Staszewsky L, Vago T, Belloli A, Di Giancamillo M, Fries M, Masson S, Scanziani E, Latini R

Postresuscitation treatment with argon improves early neurological recovery in a porcine model of cardiac arrest

Shock 2014: 41: 72-78

Ristagno G, Latini R, Vaahersalo J, Masson S, Kurola J, Varpula T, Lucchetti J, Fracasso C, Guiso G, Montanelli A, Barlera S, Gobbi M, Tiainen M, Pettilä V, Skrifvars MB, for the FINNRESUSCI Investigators

Early activation of the kynurenine pathway predicts early death and long-term outcome in patients resuscitated from out-of-hospital cardiac arrest

J Am Heart Assoc 2014; 3:e001094

Rocchetti M, Sala L, Rizzetto R, Staszewsky L, Alemanni M, Zambelli V, Russo I, Barile L, Cornaghi L, Altomare C, Ronchi C, Mostacciuolo G, Lucchetti J, Gobbi M, Latini R, Zaza A

Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension

Cardiovasc Res 2014 Epub

Schäfer Hackenhaar F, Fumagalli F, Li Volti G, Sorrenti V, Russo I, Staszewsky L, Masson S, Latini R, Ristagno G

Relationship between post-cardiac arrest myocardial oxidative stress and myocardial dysfunction in the rat

J Biomed Sci 2014, 21: 70

Sud S, Friedrich JO, Adhikari NKJ, Taccone P, Mancebo J, Polli F, Latini R, Pesenti A, Curley MAQ, Fernandez R, Chan M-C, Beuret P, Voggenreiter G, Sud M, Tognoni G, Gattinoni L, Guérin C

Effect of prone positioning during mechanical ventilation on mortality among patients with acute respiratory distress syndrome: a systematic review and meta-analysis

CMAJ 2014; 186: E381-E390

Aleksova A, Masson S, Maggioni AP, Lucci D, Fabbri G, Beretta L, Mos L, Paino AM, Nicolosi GL, Marchioli R, Tognoni G, Tavazzi L, Sinagra G, Latini R, on behalf of the GISSI-Heart Failure (GISSI-HF) Investigators

n-3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the GISSI-HF trial

Eur J Heart Fail 2013; 15: 1289-1295

Amigoni M, Bellani G, Zambelli V, Scanziani M, Farina F, Fagnani L, Latini R, Fumagalli R, Pesenti A

Unilateral acid aspiration augments the effects of ventilator lung injury in the contralateral lung

Anesthesiology 2013; 119: 642-651

Aspromonte N, Di Fusco S A, Latini R, Cruz D N, Masson S, Tubaro M, Palazzuoli A

Natriuretic peptides in acute chest pain and acute coronary syndrome: from pathophysiology to clinical and prognostic applications

Coron Artery Dis 2013; 24: 33-39

Brunelli L, Ristagno G, Bagnati R, Fumagalli F, Latini R, Fanelli R, Pastorelli R

A combination of untargeted and targeted metabolomics approaches unveils changes in the kynurenine pathway following cardiopulmonary resuscitation

Metabolomics 2013; 9: 839-852

Damman K, Masson S, Hillege HL, Voors AA, van Veldhuisen DJ, Rossignol P, Proietti G, Barbuzzi S, Nicolosi GL, Tavazzi L, Maggioni AP, Latini R

Tubular damage and worsening renal function in chronic heart failure

J Am Coll Cardiol HF 2013; 1: 417-424

Disertori M, Franzosi M G, Barlera S, Cosmi F, Quintarelli S, Favero C, Cappellini G, Fabbri G, Maggioni A P, Staszewsky L, Moroni L A, Latini R, on behalf of the GISSI-AF Investigators

Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: Data from the GISSI-AF trial

BMC Cardiovasc Disord 2013; 13: 28

Latini R, Masson S

Significance of measurable cardiac troponin by high-sensitivity assays in patients with chronic stable heart failure

Coron Artery Dis 2013; 24: 716-719

Latini R, Masson S

NT-proBNP: a guide to improve the management of patients with heart failure

eJIFCC 2013; 24: (n 3-4) 1-7

Latini R, Staszewsky L, Sun J, Bethel MA, Disertori M, Haffner SM, Holman RR, Chang F , Giles TD, Maggioni AP, Rutten GEHM , Standl E, Thomas L, Tognoni G, Califf RM, McMurray JJV

Incidence of atrial fibrillation in a population with impaired glucose tolerance: The contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial

Am Heart J 2013; 166: 935-940.e1

La Rovere MT, Staszewsky L, Barlera S, Mezzani A, Midi P, Marchioli R, Maggioni AP, Tognoni G, Tavazzi L, Latini R, on behalf of the GISSI-HF Investigators

n-3PUFA and holter derived autonomic variables in heart failure patients: Data from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) Holter Substudy

Heart Rhythm 2013; 10: 226-232

Lesogor A, Cohn J N, Latini R, Tognoni G, Krum H, Zalewski A, Kandra A, Hua T A, Gimpelewicz C

Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT study

Eur J Heart Fail 2013; 15: 1236-1244

Masson S, Latini R, Cioffi G, Urso R, Vago T, Lucci D, Mureddu G F, Tarantini L, Faggiano P, Girfoglio D, Velussi M, Maggioni AP, Giorda CB, Comaschi M, DYDA Investigators

Cardiovascular biomarkers, cardiac dysfunction, and outcomes in patients with type 2 diabetes: A prospective, multicenter study

Diabetes Care 2013; 36: e137-e138

Masson S, Latini R, Mureddu GF, Agabiti N, Miceli M, Cesaroni G, Forastiere F, Wienhues-Thelen U-H, Block D, Zaugg C, Vago T, Boccanelli R, on behalf of the Investigators of the PREDICTOR study

High-sensitivity cardiac troponin T for detect subtle abnormalities of cardiac phenotype in a general population of elderly individuals

J Inter Med 2013; 273:306-317

Masson S, Marchioli R, Mozaffarian D, Bernasconi R, Milani V, Dragani L, Tacconi MT, Marfisi R M, Borgese L, Cirrincione V, Febo O, Nicolis E, Maggioni AP, Tognoni G, Tavazzi L, Latini R, GISSI-HF Investigators

Plasma n-3 polyunsaturated fatty acids in chronic heart failure in the GISSI-Heart Failure Trial. Relation with fish intake, circulating biomarkers, and mortality

Am Heart J 2013;165:208-215.e4

Mozaffarian D, Wu JHY, de Oliveira Otto MC , Sandesara CM, Metcalf RG, Latini R, Libby P, Lombardi F, O'Gara PT, Page RL, Silletta MG, Tavazzi L, Marchioli R

Fish oil and post-operative atrial fibrillation. A meta-analysis of randomized controlled trials

J Am Coll Cardiol 2013; 61: 2194-2196

Mureddu GF, Tarantini L, Agabiti N, Faggiano P, Masson S, Latini R, Cesaroni G, Miceli M, Forastiere F, Scardovi AB, Uguccioni M, Boccanelli A

Evaluation of different strategies for identifying asymptomatic left ventricular dysfunction and pre-clinical (stage B) heart failure in the elderly. Results from "PREDICTOR", a population based-study in central Italy

Eur J Heart Fail 2013; 15: 1102-1112

Olivieri F, Antonicelli R, Recchioni R, Mariotti S , Marcheselli F, Lisa R, Spazzafumo L, Galeazzi R, Caraceni D, Testa R, Latini R, Procopio AD

Telomere/telomerase system impairment in circulating angiogenic cells of geriatric patients with heart failure

Int J Cardiol 2013; 164: 99-105

Raimondi M T, Balconi G, Boschetti F, Di Metri A, Mohammed SAA, Quaglini V, Araneo L, Galvez BG, Lupi M, Latini R, Remuzzi A

An opto-structural methods to estimate the stress-strain field induced by cell contraction on substrates of controlled stiffness in vitro

J Appl Biomater Function Mater 2013; 11: 143-150

Ristagno G, Fries M, Brunelli L, Fumagalli F, Bagnati R, Russo I, Staszewsky L, Masson S, Li Volti G, Zappalà A, Derwall M, Brücken A, Pastorelli G, Latini R

Early kynurenine pathway activation following cardiac arrest in rats, pigs, and humans

Resuscitation 2013; 84: 1604-1610

Sciorati C, Staszewsky L, Zambelli V, Russo I, Salio M, Novelli D, Di Grigoli G, Moresco R M, Clementi E, Latini R

Ibuprofen plus isosorbide dinitrate treatment in the mdx mice ameliorates dystrophic heart structure

Pharmacological Research 2013; 73:35-43

Staszewsky L, Latini R

What is the atrium trying to tell us?

Eur Heart J 2013; 34: 255-257

Talan MI, Latini R

Myocardial infarction: cardioprotection by erythropoietin

Methods Mol Biol 2013; 982: 265-302

Ueland T, Nymo SH , Latini R, McMurray JJV, Kjekshus J, Yndestad A, Fucili A, Grosu A, Masson S, Maggioni AP, Gullestad L, Aukrust P, on behalf of the Investigators of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA), GISSI-Heart Failure (GISSI-HF) trials

CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials

Eur J Heart Fail 2013; 15; 747-755

Wu JHY, Marchioli R, Silletta MG, Macchia A, Song X, Siscovick DS, Harris WS, Masson S, Latini R, Albert C, Brown NJ, Lamarra M, Favaloro RR, Mozaffarian D

Plasma phospholipid omega-3 fatty acids and incidence of postoperative atrial fibrillation in the OPERA Trial

J Am Heart Assoc 2013; 2: e000397

Aleksova A, Masson S, Maggioni AP, Lucci D, Urso R, Staszewsky L, Ciaffoni S, Cacciatore G, Misuraca G, Gulizia M, Mos L, Proietti G, Minneci C, Latini R, Sinagra G, CandHeart Investigators

Effects of candesartan on left ventricular function, aldosterone and BNP in chronic heart failure

Cardiovasc Drugs Ther 2012; 26: 131-143

Bernal A, San Martin N, Fernández M, Covarello D, Molla F, Soldo A, Latini R, Cossu G, Galvez BG

L-selectin and SDF-1 enhance the migration of mouse and human cardiac mesoangioblasts

Cell Death Differ 2012; 19: 345-355

Citerio G, Pesenti A, Latini R, Masson S, Barlera S, Gaspari F, Franzosi MG, NeuroMorfeo Study Group

A multicentre, randomised, open-label, controlled trial evaluating equivalence of inhalational and intravenous anaesthesia during elective craniotomy

Eur J Anaesthesiol 2012; 29: 371-379

Disertori M, Barlera S, Staszewsky L, Latini R, Quintarelli S, Franzosi MG

Systematic review and meta-analysis: Renin-angiotensin system inhibitors in the prevention of atrial fibrillation recurrences. An unfulfilled hope

Cardiovasc Drugs Ther 2012; 26: 47–54

Ferratini M, Ripamonti V, Masson S, Grati P, Racca V, Cuccovillo I, Raimondi E, Capomolla S, Macchi C, Coruzzi P, Vago T, Calvo M, Mantovani A, Latini R

Pentraxin-3 predicts functional recovery and 1-year major adverse cardiovascular events after rehabilitation of cardiac surgery patients

J Cardiopulm Rehabil Prev 2012; 32: 17-24

Franzosi MG, Latini R

Beta-adrenoceptor antagonists and antianginal drugs. Chapter 18

In: Aronson JK, Side Effects of Drugs. Annual 34

Elsevier, Amsterdam 2012, 303-310.

Latini R, Gullestad L, Masson S, Nymo SH , Ueland T, Cuccovillo I, Vårdal M , Bottazzi B, Mantovani A, Lucci D, Masuda N, Sudo Y, Wikstrand J, Tognoni G, Aukrust P, Tavazzi L, on behalf of the Investigators of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) and GISSI-Heart Failure (GISSI-HF) trial

Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials

Eur J Heart Fail 2012; 14: 992-999

Masson S, Anand I S, Favero C, Barlera S, Vago T, Bertocchi F, Maggioni AP, Tavazzi L, Tognoni G, Cohn JN, Latini R, on behalf of the Valsartan Heart Failure Trial (Val-HeFT) and Gruppo Italiano per lo Studio della Sopravvivenza nell’Insufficienza Cardiaca-Heart Failure ( GISSI-HF) Investigators

Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure. Data from 2 large randomized clinical trials

Circulation 2012; 125: 280-288

Meda C, Molla F, De Pizzol M, Regano D, Maione F, Capano S, Locati M, Mantovani A, Latini R, Bussolino F, Giraudo E

Semaphorin 4A exerts a proangiogenic effect by enhancing vascular endothelial growth factor-A expression in macrophages

J Immunol 2012; 188: 4081-4092

Mozaffarian D, Marchioli R, Macchia A, Silletta MG, Ferrazzi P, Gardner TJ, Latini R, Libby P, Lombardi F, O'Gara PT, Page RL, Tavazzi L, Tognoni G, for the OPERA Investigators.

Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial

JAMA 2012; 308: 2001-2011

Burba I, Colombo GI, Staszewsky LI, De Simone M, Devanna P, Nanni S, Avitabile D, Molla F, Cosentino S, Russo I, De Angelis N, Soldo A, Biondi A, Gambini E, Gaetano C, Farsetti A, Pompilio G, Latini R, Capogrossi MC, Pesce M

Histone deacetylase inhibition enhances self renewal and cardioprotection by human cord blood-derived CD34+ cells

PLoS One 2011; 6: e22158

Cioffi G, Faggiano P, Lucci D, Di Lenarda A, Mureddu GF, Tarantini L, Verdecchia P, Comaschi M, Giorda CB, Velussi M, Chinali M, Latini R, Masson S, De Simone G, DYDA Investigators

Inappropriately high left ventricular mass in patients with type 2 diabetes mellitus and no overt cardiac disease. The DYDA study

J Hypertens 2011; 29: 1994-2003

Damman K, Masson S, Hillege HL, Maggioni AP, Voors AA, Opasich C, van Veldhuisen DJ, Montagna L, Cosmi F, Tognoni G, Tavazzi L, Latini R

Clinical outcome of renal tubular damage in chronic heart failure

Eur Heart J 2011; 32: 2705–2712

de Simone G, Chinali M, Mureddu GF, Cacciatore G, Lucci D, Latini R, Masson S, Vanasia M, Maggioni AP, Boccanelli A, AREA IN-CHF Investigators

Effect of canrenone on left ventricular mechanics in patients with mild systolic heart failure and metabolic syndrome: The AREA-IN-CHF study

Nutr Metab Cardiovasc Dis 2011; 21: 783-791

Disertori M, Lombardi F, Barlera S, Maggioni AP, Favero C, Franzosi MG, Lucci D, Staszewsky L, Fabbri G, Quintarelli S, Bianconi L, Latini R

Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial

Am Heart J 2011; 162: 382-389

Finzi AA, Latini R, Barlera S, Rossi MG, Ruggeri A, Mezzani A, Favero C, Franzosi MG, Serra D, Lucci D, Bianchini F, Bernasconi R, Maggioni AP, Nicolosi GL, Porcu M, Tognoni G, Tavazzi L, Marchioli R

Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial

Am Heart J 2011; 161: 338-343.e1

Franzosi MG, Latini R

Beta-adrenoceptor antagonists and antianginal drugs. Chapter 18

In: Side effects of drugs. Annual 33.

Elsevier, Amsterdam,2011; 397-406

Giorda CB, Cioffi G, de Simone G, Di Lenarda A, Faggiano P, Latini R, Lucci D, Maggioni AP, Tarantini L, Velussi M, Verdecchia P, Comaschi M, DYDA Investigators

Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA study

Eur J Cardiovasc Prev Rehabil 2011; 18: 415-423

Gunetti M, Noghero A, Molla F, Staszewsky LI, De Angelis N, Soldo A, Russo I, Errichiello E, Frasson C, Rustichelli D, Ferrero I, Gualandris A, Berger M, Geuna M, Scacciatella P, Basso G, Marra S, Bussolino F, Latini R, Fagioli F

Ex vivo-expanded bone marrow CD34+ for acute myocardial infarction treatment: in vitro and in vivo studies

Cytotherapy 2011; 13: 1140-1152

Latini R, Masson S, Pirelli S, Barlera S, Pulitano' G, Carbonieri E, Gulizia M, Vago T, Favero C, Zdunek D, Struck J, Staszewsky L, Maggioni AP, Franzosi MG, Disertori M, GISSI-AF Investigators

Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-Atrial Fibrillation Trial

J Intern Med 2011; 269: 160-171

Masson S, Gori F, Latini R, Milani V, Flyvbjerg A, Frystyk J, Crociati L, Pietri S, Vago T, Barlera S, Maggioni AP, Tognoni G, Tavazzi L, Omland T, Franzosi MG, GISSI-HF Investigators

Adiponectin in chronic heart failure: influence of diabetes and genetic variants

Eur J Clin Invest 2011; 41: 1330-1338

Mozaffarian D, Marchioli R, Gardner T, Ferrazzi P, O'Gara P, Latini R, Libby P, Lombardi F, Macchia A, Page R, Santini M, Tavazzi L, Tognoni G, Masson S

The ω-3 fatty acids for prevention of post-operative atrial fibrillation trial—rationale and design

Am Heart J 2011; 162: 56-63.e3

Pitt B, Latini R, Maggioni AP, Solomon SD, Smith BA, Wright M, Prescott MF, McMurray JJV

Neurohumoral effects of aliskiren in patients with symptomatic heart failure receiving a mineralocorticoid receptor antagonist: the Aliskiren Observation of Heart Failure Treatment study

Eur J Heart Fail 2011; 13: 755-764

Riess I, Sala V, Leo C, Demaria M, Gatti S, Gallo S, Fitou A, Boero O, Levi R, Cuccovillo I, Molla F, De Angelis N, Staszewsky L, Latini R, Crepaldi T

A mouse model for spatial and temporal expression of HGF in the heart

Transgenic Res 2011; 20: 1203–1216

Scanziani M, Amigoni M, Bellani G, Zambelli V, Masson S, Radaelli E, Pesenti A, Latini R

The effect of a single bolus of exogenous surfactant on lung compliance persists until two weeks after treatment in a model of acid aspiration pneumonitis

Pulm Pharmacol Ther 2011; 24: 141-146

Sidik NP, Solomon SD, Latini R, Maggioni AP, Wright M, Gimpelewicz CR, Pitt B, McMurray JJV

Effect of aliskiren in patients with heart failure according to background dose of ACE inhibitor: a retrospective analysis of the Aliskiren Observation of Heart Failure Treatment (ALOFT) Trial

Cardiovasc Drugs Ther 2011; 25: 315-321

Staszewsky L, Wong M, Masson S, Raimondi E, Gramenzi S, Proietti G, Bicego D, Emanueli C, Pulitano' G, Taddei F, Nicolis EB, Correale E, Fabbri G, Bertocchi C, Franzosi MG, Maggioni AP, Tognoni G, Disertori M, Latini R, GISSI-AF Investigators

Left atrial remodeling and response to valsartan in the prevention of recurrent atrial fibrillation: the GISSI-AF echocardiographic substudy

Circ Cardiovasc Imaging 2011; 4: 721-728

Zambelli V, Santaniello A, Fumagalli F, Masson S, Scorza R, Beretta L, Latini R

Efficacy of aminaftone in a rat model of monocrotaline-induced pulmonary hypertension

Eur J Pharmacol 2011; 667: 287-291

Aspromonte N, Di Tano G, Latini R, Masson S, Valle R, Emdin M

Ruolo dei biomarcatori per la stratificazione prognostica e la personalizzazione del follow-up nel paziente con scompenso cardiaco

G Ital Cardiol 2010; 11: 17s-23s

Disertori M, Lombardi F, Barlera S, Latini R, Maggioni AP, Zeni P, Di Pasquale G, Cosmi F, Franzosi MG, on behalf of the GISSI-AF Investigators

Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico–Atrial Fibrillation (GISSI-AF) trial

Am Heart J 2010; 159: 857-863

Franzosi MG, Latini R

Beta-adrenoceptor antagonists and antianginal drugs

In: Side effects of drugs. Annual 32.
Elsevier, Amsterdam,2010;363-369

Ghezzi P, Bernaudin M, Bianchi R, Blomgren K, Brines M, Campana W, Cavaletti G, Cerami A, Chopp M, Coleman T, Digicaylioglu M, Ehrenreich H, Erbayraktar S, Erbayraktar Z, Gassmann M, Genc S, Gokmen N, Grasso G, Juul S, Lipton SA, Hand CC, Latini R, Lauria G, Leist M, Newton SS, Petit E, Probert L, Sfacteria A, Siren AL, Talan M, Thiemermann C, Westenbrink D, Yaqoob M, Zhu C.

Erythropoietin: not just about erythropoiesis

Lancet 2010; 375: 2142